Skip to main content

Table 1 Expression of APMCF1 in normal and malignant human tissues

From: Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues

Tissue type Sample size Score
Liver   
   carcinoma tissues 2 +++/+++
   tumor-adjacent tissues 2 ++/++
   normal tissues 2 ++/+
Lung   
   carcinoma tissues 2 +++/+++
   tumor-adjacent tissues 2 +/+
   normal tissues 2 +/+
Breast   
   carcinoma tissues 2 ++/+++
   tumor-adjacent tissues 2 ++/+
   normal tissues 2 +/-
Stomach   
   carcinoma tissues 2 ++/++
   tumor-adjacent tissues 2 +/-
   normal tissues 2 -/-
Colon   
   carcinoma tissues 2 +++/+++
   tumor-adjacent tissues 2 +/+
   normal tissues 2 ++/-
Ovary   
   carcinoma tissues 2 -/-
   tumor-adjacent tissues 2 -/-
   normal tissues 2 -/-
Esophagus   
   carcinoma tissues 2 +++/+++
   tumor-adjacent tissues 2 ++/+++
   normal tissues 2 +/+
Brain   
   glioma tissues 2 -/-
   tumor-adjacent tissues 2 +/-
   normal tissues 2 +/+
Testis   
   seminoma tissues 2 ++/+
   tumor-adjacent tissues 2 +/-
   normal tissues 2 +/-
  1. As indicated in the Methods section, APMCF1 immunolabeling was scored as follows: weak immunolabeling (+), moderate immunolabeling (++), strong immunolabeling (+++), and no immunolabeling (-).